Has Henry Zhu received payments from drug or device companies?

Yes. Drug and device makers reported $3,580 in general payments to Henry Zhu across 158 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Zhu did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Zhu come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Zhu

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Sacramento, CANPI 1144249376

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Lilly USA, LLC at 45.3% of the total. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in CA, where the typical reported total is $4,430.

$3,580in general payments, 2019–2025

Across 158 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$2K
Johnson & Johnson$973
LEO Pharma Inc.$374
Galderma Laboratories, L.p.$107
Sun Pharmaceutical Industries Inc.$95
Boehringer Ingelheim$91
plus $317 from 8 others

What the payments were for

Food & beverage$3,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	60	$1,623
Johnson & Johnson	42	$973
LEO Pharma Inc.	31	$374
Galderma Laboratories, L.p.	5	$107
Sun Pharmaceutical Industries Inc.	4	$95
Boehringer Ingelheim	3	$91
AbbVie	2	$58
Artivion, Inc.	1	$50
Regeneron Healthcare Solutions, Inc.	2	$49
Atricure, Inc.	3	$48
Sanofi	1	$40
Biofrontera Inc.	2	$32
Organogenesis Inc.	1	$23
Abiomed	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$150

How this compares

$3,580 in reported general payments places this provider in the 45th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Other thoracic surgery (cardiothoracic vascular surgery) in Sacramento

Frank SlachmanSacramento$240K
Bob KiaiiSacramento$195K
David CookeSacramento$59K
Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Armin KiankhooySaint Helena$941K
Ara KlijianMurrieta$916K
Gregory FontanaThousand Oaks$875K
Gansevoort DunningtonSaint Helena$764K
Wilson TsaiWalnut Creek$680K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →